Seattle Genetics (SGEN) Set to Resume Trading at 5:05PM ET
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Join SI Premium – FREE
Seattle Genetics (Nasdaq: SGEN) to resume trading at 5:05PM ET after FDA advisory committee in votes in favor of accelerated approval of ADCETRIS.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Gossamer Bio raises up to $250M in private placement for PAH drug
- FDA grants fast track status to Rein Therapeutics drug for lung fibrosis
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
